You are here

DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 75N91023C00060
Agency Tracking Number: 75N91023C00060
Amount: $3,499,793.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: AH02
Solicitation Number: 75N91023R00041
Timeline
Solicitation Year: 2023
Award Year: 2023
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
330 Billerica Road Unit 200
CHELMSFORD, MA 01824-4053
United States
DUNS: 796010411
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 KEN MAHMUD
 (508) 740-9297
 KMahmud@tritonsys.com
Business Contact
 COLLETTE JOLLIFFE
Phone: (603) 234-8476
Email: cjolliffe@tritonsystems.com
Research Institution
N/A
Abstract

Triton Systems Inc. will create a transdermal microneedle patch and portable on-body pump system for therapeutic drug delivery for cardiovascular disease management (CVD) and intervention. The device will offer the capability for real-time remote management of therapeutic dosages by medical staff through communication with patient-specific electronic health records (EHRs), while remaining HIPAA-compliant. The platform will monitor patient vital signs by leveraging commercially available technology.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government